Physician profile
Rasheed I Ahmad
NPI 1295732345
$8,741.55
in general payments reported to CMS, 2019-2025
9 companies · $2,479 in 2025
The $2,479 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $375 · 2021: $4,055 · 2022: $59.97 · 2023: $167 · 2024: $1,606 · 2025: $2,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,436 · Travel and Lodging: $1,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,436.38 |
| Travel and Lodging | $1,814.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $2,431.06 | 2021 | |
| Sonex Health, INC. | $1,618.29 | 2025 | Sx-One Microknife |
| Acumed LLC | $1,576.70 | 2023-2024 | Acumed, Innate Implant, Inframe Implant |
| Arthrex, INC. | $1,496.00 | 2021 | |
| Axogen | $979.58 | 2021-2025 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $259.52 | 2020 | |
| Boston Scientific Corporation | $212.11 | 2021-2025 | General - Pain Management |
| Zimmer Biomet Holdings, INC. | $136.12 | 2020-2024 | Avenir |
| Pacira Pharmaceuticals Incorporated | $32.17 | 2022-2024 | Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rasheed Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.